Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate
Withdrawn before enrolling · Not applicable
Conditions studied: Colonic Polyps
In brief
The purpose of this investigator-initiated study is to determine whether the use of an accessory device called AmplifEYE can improve colonoscopy quality in patients who are undergoing average risk colorectal cancer screening. Primary end point is adenoma detection rates.
Key facts
- Study ID
- NCT02885987
- Run by
- Loma Linda University
- People needed
- 0
- Starts
- 2017-08-03
- Expected to finish
- 2022-03-01
- Last updated by the study team
- 2020-10-20
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All adult patients greater than or at 50 years of age who are referred for average risk screening colonoscopy.
You may not qualify if…
- Any pregnant patient
- Patient's that are unable to provide consent for themselves
- Any patient undergoing diagnostic colonoscopy (IBD, rectal bleeding, recent change in bowel habits, etc.)
- Any patient undergoing surveillance (prior history of polyps or colorectal cancer)
- Any patient undergoing high risk screening colonoscopy (family history of colon cancer in first degree family member <65 years of age, or co-existing conditions that pre-dispose to colon cancer such as polyposis syndromes, PSC or IBD)
- Prior history of any cancer
- Current or past immunosuppression (due to either infection or medications)
- Coagulation disorder OR use of anti-coagulation or anti-platelet therapy other than aspirin within 5-7 days of procedure
- Colonic strictures
- suspected intestinal obstruction or colonic pseudo-obstruction
- history of colon resection
- active infection
- active inflammation (including diverticulitis)
Where it is running
- Loma Linda University Medical Center — Loma Linda, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.